Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg approved by FDA

Dr. Reddy’s Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg is an over-the-counter proton pump inhibitor for treating frequent heartburn in adults. It is a therapeutic equivalent generic version of Nexium (registered trademark of AstraZeneca AB) 24HR Capsules and has been approved for the US market by the FDA. Combined sales of these products in the USA was around $311m in the last 12 month period.
Milan Kalawadia, Vice President and Head, US OTC and Speciality Rx businesses, Dr. Reddy’s Laboratories, said: “This launch continues to demonstrate our deep R&D and manufacturing capabilities to bring newer store-brand OTC medications to the market. We look forward to collaborating with our customers to provide high-quality, affordable alternatives to consumers.”